Literature DB >> 26381534

Relation of Lipid Content of Coronary Plaque to Level of Serum Uric Acid.

Yuichi Saito1, Takashi Nakayama2, Kazumasa Sugimoto2, Yoshihide Fujimoto2, Yoshio Kobayashi2.   

Abstract

Elevated serum uric acid (SUA) level is known to be a prognostic factor in patients with acute coronary syndrome (ACS). However, the pathogenesis of the relation between SUA level and coronary plaque characteristics has not been fully evaluated. The aim of this study was to investigate the relation between SUA level and plaque composition of nonculprit lesions in patients with ACS. A total of 81 patients with ACS who underwent intravascular ultrasound (IVUS)-guided percutaneous coronary intervention were included. They were classified into 3 groups according to tertiles of SUA level. Using integrated backscatter (IB)-IVUS system, tissue components were classified into 4 categories: calcium deposits, dense fibrosis, fibrosis, and lipid. Tertiles of SUA level were as follows: low tertile <5.0 mg/dl; intermediate tertile 5.0 to 6.4 mg/dl; and high tertile >6.4 mg/dl. There was a trend toward greater vessel volume in the high tertile group than in the low and intermediate tertile groups (19.4 ± 3.7 vs 17.4 ± 4.4 vs 16.7 ± 4.1 mm(3)/mm, p = 0.05). There was no significant difference in lumen volume between the 3 groups. Plaque volume was significantly greater in the high than in the low tertile group (8.6 ± 2.4 vs 6.7 ± 2.2 mm(3)/mm, p = 0.01). IB-IVUS analysis demonstrated greater lipid (59.1 ± 9.1% vs 49.7 ± 10.9% vs 51.1 ± 9.3%, p = 0.001) and less fibrous components (36.8 ± 7.8% vs 44.3 ± 7.8% vs 43.2 ± 6.7%, p <0.001) in the high than in the low and intermediate tertile groups. Multivariate analysis showed high SUA as an independent predictor of increasing lipid volume. In conclusion, elevated SUA level is associated with greater lipid content of coronary plaque in patients with ACS than in patients with normal levels.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26381534     DOI: 10.1016/j.amjcard.2015.07.059

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Empagliflozin reduces blood pressure and uric acid in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Di Zhao; Hui Liu; Pingshuan Dong
Journal:  J Hum Hypertens       Date:  2018-11-15       Impact factor: 3.012

Review 2.  Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

Authors:  Claudio Borghi; Alberto Palazzuoli; Matteo Landolfo; Eugenio Cosentino
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

Review 3.  Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.

Authors:  Thomas Bardin; Pascal Richette
Journal:  BMC Med       Date:  2017-07-03       Impact factor: 8.775

4.  Correlation of Serum Uric Acid Levels with Nonculprit Plaque Instability in Patients with Acute Coronary Syndromes: A 3-Vessel Optical Coherence Tomography Study.

Authors:  Donghui Zhang; Ruoxi Zhang; Ning Wang; Lin Lin; Bo Yu
Journal:  Biomed Res Int       Date:  2018-02-07       Impact factor: 3.411

5.  The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: a cross-sectional study.

Authors:  Jing Liang; Yutong Jiang; Yefei Huang; Wei Song; Xiaomin Li; Yulan Huang; Jiayong Ou; Qiujing Wei; Jieruo Gu
Journal:  Lipids Health Dis       Date:  2020-03-03       Impact factor: 3.876

6.  Effect of Asymptomatic Hyperuricemia on Mortality of Elderly Patients After Elective Percutaneous Coronary Intervention.

Authors:  Chen Chen; Jianzeng Dong; Qiang Lv; Xinmin Liu; Qian Zhang; Xin Du
Journal:  Front Cardiovasc Med       Date:  2022-03-17

Review 7.  Uric Acid-An Emergent Risk Marker for Thrombosis?

Authors:  Laura Țăpoi; Delia Lidia Șalaru; Radu Sascău; Cristian Stătescu
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.964

8.  Off target effects of statins shape total mortality?

Authors:  Vasilios G Athyros; Niki Katsiki; Asterios Karagiannis
Journal:  J Drug Assess       Date:  2016-04-05

9.  Serum uric acid is associated with coronary artery calcification in early chronic kidney disease: a cross-sectional study.

Authors:  Miyeun Han; Hyunsuk Kim; Hyo Jin Kim; Eunjeong Kang; Yong-Soo Kim; Kyu Hun Choi; Soo Wan Kim; Curie Ahn; Kook-Hwan Oh
Journal:  BMC Nephrol       Date:  2021-07-04       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.